{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:52:07Z","timestamp":1792803127153,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116241","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T23:08:52Z","timestamp":1707260932000},"page":"116241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The water extract of Amydrium sinense (Engl.) H. Li ameliorates Isoproterenol-induced cardiac hypertrophy through inhibiting the NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"172","author":[{"given":"Bingmin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhua","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-8097","authenticated-orcid":false,"given":"Jingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2024.116241_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116241_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-022-00756-z","article-title":"Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure","volume":"20","author":"Kamel","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116241_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.116241_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116241_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41392-023-01378-8","article-title":"Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"49","key":"10.1016\/j.biopha.2024.116241_bib6","doi-asserted-by":"crossref","first-page":"31353","DOI":"10.1073\/pnas.2011614117","article-title":"A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction","volume":"117","author":"Mullany","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2024.116241_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Linthout, Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116241_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/tox.22999","article-title":"Swietenine extracted from Swietenia relieves myocardial hypertrophy induced by isoprenaline in mice","volume":"35","author":"Ding","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116241_bib9","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41401-021-00820-3","article-title":"Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-\u03baB pathways","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2024.116241_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.03.025","article-title":"Regulation of Nuclear Factor-KappaB (NF-\u03baB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?","volume":"509","author":"Mirzaei","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116241_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.05.026","article-title":"In response to \"Comment on \"Regulation of Nuclear Factor-KappaB (NF-\u03baB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?\" Cancer Lett. 2021 May 2; 509 (2021) 63-80\"","volume":"516","author":"Mirzaei","year":"2021","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.biopha.2024.116241_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biom9120878","article-title":"Hypertrophic cardiomyopathy: an overview of genetics and management","volume":"9","author":"Teekakirikul","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116241_bib13","doi-asserted-by":"crossref","first-page":"1101703","DOI":"10.3389\/fphar.2023.1101703","article-title":"Aqueous extract of Amydrium sinense (Engl.) H. Li alleviates hepatic fibrosis by suppressing hepatic stellate cell activation through inhibiting Stat3 signaling","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116241_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bph.14538","article-title":"Sirtuin 1 represses PKC-\u03b6 activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116241_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105104","article-title":"Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L\/\u03b2-catenin","volume":"161","author":"Cai","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2024.116241_bib16","doi-asserted-by":"crossref","first-page":"1043022","DOI":"10.3389\/fphar.2022.1043022","article-title":"Yao medicine Amydrium hainanense suppresses hepatic fibrosis by repressing hepatic stellate cell activation via STAT3 signaling","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116241_bib17","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/bph.13091","article-title":"The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1","volume":"172","author":"Feng","year":"2015","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116241_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2018.05.009","article-title":"JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing \u03b2-MHC expression","volume":"477","author":"Guo","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2024.116241_bib19","article-title":"Uncovering the effect and mechanism of rhizoma corydalis on myocardial infarction through an integrated network pharmacology approach and experimental verification","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116241_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jphs.2016.03.010","article-title":"PKC\u03b6 interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy","volume":"132","author":"Li","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116241_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.992","article-title":"Tetramisole is a new IK1 channel agonist and exerts IK1 -dependent cardioprotective effects in rats","volume":"10","author":"Liu","year":"2022","journal-title":"Pharm. Res. Perspect."},{"issue":"12","key":"10.1016\/j.biopha.2024.116241_bib22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.121.319737","article-title":"Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis","volume":"129","author":"Revelo","year":"2021","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116241_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.116241_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.intimp.2017.12.019","article-title":"Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4\/NF-\u03baB signaling pathway in mice","volume":"55","author":"Ma","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116241_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","article-title":"Essential biochemistry and physiology of (NT-pro)BNP","volume":"6","author":"Hall","year":"2004","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.biopha.2024.116241_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116241_bib27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116241_bib28","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","article-title":"Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction","volume":"118","author":"Zhao","year":"2016","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.biopha.2024.116241_bib29","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","article-title":"Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways","volume":"105","author":"Honsho","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.116241_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113559","article-title":"Peppermint essential oil: its phytochemistry, biological activity, pharmacological effect and application","volume":"154","author":"Zhao","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2024.116241_bib31","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jep.2013.10.017","article-title":"Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4\/NF-\u043aB signaling pathway in isoproterenol-induced myocardial hypertrophy","volume":"150","author":"Yang","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116241_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","article-title":"The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy","volume":"12","author":"Oduro","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.biopha.2024.116241_bib33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.pharep.2017.03.004","article-title":"The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats","volume":"69","author":"Lamas","year":"2017","journal-title":"Pharmacol. Rep.: PR"},{"key":"10.1016\/j.biopha.2024.116241_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bcp.2017.02.016","article-title":"Protein kinase CK2\u03b1 catalytic subunit ameliorates diabetic renal inflammatory fibrosis via NF-\u03baB signaling pathway","volume":"132","author":"Huang","year":"2017","journal-title":"Biochem. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:46:34Z","timestamp":1760103994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"alternative-id":["S0753332224001227"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116241","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The water extract of Amydrium sinense (Engl.) H. Li ameliorates Isoproterenol-induced cardiac hypertrophy through inhibiting the NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116241"}}